| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/05/2026 | ±2.1% | -0.0% | over-priced |
| 05/07/2026 | ±1.6% | -1.3% | over-priced |
| 11/05/2025 | ±2.2% | +0.3% | over-priced |
| 08/06/2025 | ±2.4% | +1.2% | over-priced |
| 05/07/2025 | ±4.6% | +0.5% | over-priced |
| 11/06/2024 | ±2.0% | +6.3% | under-priced |
| 08/07/2024 | ±3.3% | -0.2% | over-priced |
| 05/08/2024 | ±5.0% | +5.1% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $3.65 | $1.6B | $288M |
| Q1 FY2026 | $3.39 | $1.6B | $271M |
| Q4 FY2025 | $3.30 | $1.5B | $266M |
| Q3 FY2025 | $4.73 | $1.5B | $388M |
Globe Life Inc. (GL) reports in 75 days, with the next report estimated for 11/26/2026. Across the last 8 reports, options priced an average ±2.9% earnings move while the stock actually moved 1.9% on average — the market has systematically over-priced GL's earnings risk. Fundamentals into the print: EPS up 19.7% year-over-year, revenue up 8.0%. QuantLogix's live 5-factor engine currently reads GL as a underweight at 38/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →